We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Prior to this trial, CS014 had positive outcomes in an ...
A team of scientists and physicians at Mass General Brigham has developed a single-dose oral cholera vaccine and tested it in ...
President Donald Trump, joined by Chinese Vice Premier Liu He, sign the U.S.-China Phase One trade agreement in 2020. (White House photo) Farm organizations are warning the Trump administration that ...
The Rochester Broadway Theatre League has finished phase one of its project restoration! Phase one focused on enhanced ...
Vigil Neuroscience reported positive Phase 1 trial results for VG-3927 and plans a Phase 2 trial in Q3 2025. Vigil Neuroscience, Inc. announced promising outcomes from a Phase 1 clinical trial of ...
Interim data from Phase 1 with single and multiple ascending doses show no safety signals and a generally favorable tolerability profile of AGMB-447 in healthy participants -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback